These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3071066)

  • 21. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension.
    Martinka E; Ocenásová A; Kamenistiaková L; Dobrota D; Kerný J; Mokán M
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):667-76. PubMed ID: 9657625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.
    Konrad T; Vicini P; Kusterer K; Höflich A; Assadkhani A; Böhles HJ; Sewell A; Tritschler HJ; Cobelli C; Usadel KH
    Diabetes Care; 1999 Feb; 22(2):280-7. PubMed ID: 10333946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of ke-tang-Ling administration on the function of pancreatic islets cells in non-insulin-dependent diabetes mellitus].
    Wang Z; Yin Z
    Zhong Xi Yi Jie He Za Zhi; 1990 Mar; 10(3):137-40, 130. PubMed ID: 2199090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.
    Golay A; Swislocki AL; Chen YD; Reaven GM
    Metabolism; 1987 Jul; 36(7):692-6. PubMed ID: 3298937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
    Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
    Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma lactate concentration in obesity and type 2 diabetes.
    Chen YD; Varasteh BB; Reaven GM
    Diabete Metab; 1993; 19(4):348-54. PubMed ID: 8293860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.
    Calles-Escandon J; Jaspan J; Robbins DC
    Diabetes Care; 1989; 12(10):709-14. PubMed ID: 2693010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin release and peripheral sensitivity at the oral glucose tolerance test.
    Cederholm J; Wibell L
    Diabetes Res Clin Pract; 1990 Oct; 10(2):167-75. PubMed ID: 2261853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.
    Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G
    Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
    Persson B; Hanson U; Hartling SG; Binder C
    Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
    Jenssen T; Nurjhan N; Consoli A; Gerich JE
    J Clin Invest; 1990 Aug; 86(2):489-97. PubMed ID: 2200805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.